These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1153303)

  • 21. [Bismuth-induced encephalopathies. Report and commentaries apropos of 15 cases in the Lyon area].
    Moindrot J; Evreux JC; Savet JF; Aimard G
    Lyon Med; 1977 Dec; 238(20):537-41. PubMed ID: 599952
    [No Abstract]   [Full Text] [Related]  

  • 22. [The bismuth-encephalopathy - a new pathological syndrome (author's transl)].
    Eichler I
    Wien Klin Wochenschr; 1979 Apr; 91(9):314-20. PubMed ID: 109997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Letter: Bismuth induced encephalopathy in a pregnant woman].
    Quereux C; Ezes H; Wahl P; Morice J; Level G
    Nouv Presse Med; 1975 Sep; 4(31):2275. PubMed ID: 1178500
    [No Abstract]   [Full Text] [Related]  

  • 24. [Myoclonic bismuth-induced encephalopathy. Case report (author's transl)].
    Loseke N; Retif J; Coune A; Soebert A; Molle L; D'haens J
    Acta Gastroenterol Belg; 1978; 41(1-2):72-80. PubMed ID: 665114
    [No Abstract]   [Full Text] [Related]  

  • 25. [Apropos of the 18th case of bismuth encephalopathy recognized in Belgium].
    Lotstra F; Soebert A; Linkowski P; Mendlewicz J
    Acta Neurol Belg; 1983; 83(3):135-41. PubMed ID: 6613516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bismuth myoclonic encephalopathies. Their course and lasting or definitive late complications].
    Buge A; Rancurel G; Dechy H
    Rev Neurol (Paris); 1977; 133(6-7):401-15. PubMed ID: 929035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Too much bismuth].
    Barbizet J; Degos JD; Lamotte J
    Ann Med Interne (Paris); 1978 Jan; 129(1):77-80. PubMed ID: 637465
    [No Abstract]   [Full Text] [Related]  

  • 28. [Bismuth salts used in gastro-enterology. Data from animal investigations (author's transl)].
    Bouvet P
    Ann Pharm Fr; 1981 Feb; 38(5):447-54. PubMed ID: 7011157
    [No Abstract]   [Full Text] [Related]  

  • 29. [Osteo-articular lesions observed in acute bismuth encephalopathies. A propos of 2 cases].
    Garcia JL; Penin F; Weber M; Regent MC; Cuny G
    Rev Rhum Mal Osteoartic; 1980 Apr; 47(4):275-80. PubMed ID: 7384730
    [No Abstract]   [Full Text] [Related]  

  • 30. [Myoclonic encephalopathy caused by bismuth].
    Nogué Xarau S; Sanz Gallén P
    Rev Clin Esp; 1990 Feb; 186(3):145. PubMed ID: 2356356
    [No Abstract]   [Full Text] [Related]  

  • 31. [Bismuth encephalopathy in pregnant women. Apropos of a case].
    Quéreux C; Morice J; Level G; Ezes H; Wahl P
    J Gynecol Obstet Biol Reprod (Paris); 1976; 5(1):97-103. PubMed ID: 956618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and electroencephalographic correlates in bismuth-induced myoclonic encephalopathy].
    Gastaut JL; Jouglard J
    Therapie; 1980; 35(3):293-6. PubMed ID: 7423414
    [No Abstract]   [Full Text] [Related]  

  • 33. [Bismuth encephalopathies outside France (author's transl)].
    Lagier G
    Therapie; 1980; 35(3):315-7. PubMed ID: 7423419
    [No Abstract]   [Full Text] [Related]  

  • 34. [The relationship between the course of bismuth encephalopathy and the amount of bismuth in blood and urine].
    Boiteau HL; Cler JM; Mathé JF; Delobel R; Fève J
    Eur J Toxicol Environ Hyg; 1976; 9(4):233-9. PubMed ID: 976332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bismuth preparations--encephalopathy].
    Myren J; Sigstad H
    Tidsskr Nor Laegeforen; 1978 Feb; 98(6):333. PubMed ID: 635868
    [No Abstract]   [Full Text] [Related]  

  • 36. [Poisoning by bismuth salts].
    Sanz Gallén P; Nogué Xarau S
    Med Clin (Barc); 1985 Apr; 84(13):538-41. PubMed ID: 3889518
    [No Abstract]   [Full Text] [Related]  

  • 37. [Epidemiological aspects of the encephalopathies resulting from oral administration of bismuth (author's transl)].
    Martin-Bouyer G; Foulon B; Guerbois H; Barin C
    Therapie; 1980; 35(3):307-13. PubMed ID: 7423418
    [No Abstract]   [Full Text] [Related]  

  • 38. [Encephalopathy during oral treatment with bismuth salts].
    Michaud PA; Regli F
    Schweiz Med Wochenschr; 1976 Apr; 106(16):550-5. PubMed ID: 988634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversible encephalopathy possibly associated with bismuth subgallate ingestion.
    Burns R; Thomas DW; Barron VJ
    Br Med J; 1974 Feb; 1(5901):220-3. PubMed ID: 4818163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Letter: Bismuth encephalopathy. 4 cases observed in a general medical department].
    Aimez P; Bigorie B; Bour H; Gazengel J; Guy-Grand B
    Nouv Presse Med; 1975 May; 4(20):1505. PubMed ID: 1215151
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.